Validation of a targeted metabolomics panel for improved second-tier newborn screening.
J Inherit Metab Dis
; 46(2): 194-205, 2023 03.
Article
in En
| MEDLINE
| ID: mdl-36680545
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neonatal Screening
/
Ornithine Carbamoyltransferase Deficiency Disease
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Limits:
Humans
/
Newborn
Language:
En
Journal:
J Inherit Metab Dis
Year:
2023
Type:
Article
Affiliation country:
United States